Lazard Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $41.8M | Sell |
299,734
-1,053
| -0.4% | -$147K | 0.07% | 237 |
|
|
2025
Q4 | $36.9M | Sell |
300,787
-36,681
| -11% | -$4.46M | 0.06% | 236 |
|
|
2025
Q3 | $37.5M | Sell |
337,468
-3,765
| -1% | -$428K | 0.05% | 224 |
|
|
2025
Q2 | $37.8M | Sell |
341,233
-24,414
| -7% | -$2.6M | 0.05% | 264 |
|
|
2025
Q1 | $41M | Sell |
365,647
-34,934
| -9% | -$3.6M | 0.06% | 214 |
|
|
2024
Q4 | $37M | Sell |
400,581
-43,565
| -10% | -$3.92M | 0.05% | 244 |
|
|
2024
Q3 | $37.2M | Sell |
444,146
-516,836
| -54% | -$39.4M | 0.05% | 244 |
|
|
2024
Q2 | $65.9M | Sell |
960,982
-8,751
| -0.9% | -$584K | 0.08% | 182 |
|
|
2024
Q1 | $71M | Buy |
969,733
+24,683
| +3% | +$1.9M | 0.09% | 180 |
|
|
2023
Q4 | $76.6M | Buy |
945,050
+246,614
| +35% | +$19.2M | 0.1% | 157 |
|
|
2023
Q3 | $52.3M | Sell |
698,436
-248,784
| -26% | -$19.1M | 0.07% | 199 |
|
|
2023
Q2 | $73M | Sell |
947,220
-251,974
| -21% | -$20.1M | 0.09% | 177 |
|
|
2023
Q1 | $99.5M | Buy |
1,199,194
+354,971
| +42% | +$29.4M | 0.13% | 139 |
|
|
2022
Q4 | $72.5M | Buy |
844,223
+324,758
| +63% | +$25.7M | 0.1% | 171 |
|
|
2022
Q3 | $32M | Buy |
519,465
+121,154
| +30% | +$7.64M | 0.05% | 301 |
|
|
2022
Q2 | $24.6M | Buy |
398,311
+190,766
| +92% | +$11.8M | 0.03% | 378 |
|
|
2022
Q1 | $12.3M | Buy |
207,545
+24,215
| +13% | +$1.55M | 0.01% | 566 |
|
|
2021
Q4 | $13.3M | Buy |
183,330
+171,828
| +1,494% | +$11.8M | 0.01% | 566 |
|
|
2021
Q3 | $803K | Buy |
11,502
+6,956
| +153% | +$489K | ﹤0.01% | 1102 |
|
|
2021
Q2 | $312K | Sell |
4,546
-113,359
| -96% | -$7.57M | ﹤0.01% | 1148 |
|
|
2021
Q1 | $7.62M | Sell |
117,905
-61,190
| -34% | -$3.95M | 0.01% | 604 |
|
|
2020
Q4 | $10.4M | Sell |
179,095
-111,173
| -38% | -$6.71M | 0.01% | 543 |
|
|
2020
Q3 | $18.3M | Sell |
290,268
-139,430
| -32% | -$9.67M | 0.03% | 406 |
|
|
2020
Q2 | $33.1M | Buy |
429,698
+333,717
| +348% | +$25.6M | 0.05% | 264 |
|
|
2020
Q1 | $7.17M | Sell |
95,981
-259,807
| -73% | -$18M | 0.01% | 480 |
|
|
2019
Q4 | $23.1M | Buy |
355,788
+7,763
| +2% | +$506K | 0.03% | 318 |
|
|
2019
Q3 | $22.1M | Buy |
348,025
+67,995
| +24% | +$4.44M | 0.04% | 325 |
|
|
2019
Q2 | $18.9M | Buy |
280,030
+66,542
| +31% | +$4.38M | 0.03% | 356 |
|
|
2019
Q1 | $13.9M | Buy |
213,488
+44,885
| +27% | +$2.98M | 0.02% | 362 |
|
|
2018
Q4 | $10.5M | Buy |
168,603
+29,178
| +21% | +$2.04M | 0.02% | 377 |
|
|
2018
Q3 | $10.8M | Sell |
139,425
-849,980
| -86% | -$64.2M | 0.02% | 429 |
|
|
2018
Q2 | $70.1M | Buy |
989,405
+15,846
| +2% | +$1.12M | 0.12% | 142 |
|
|
2018
Q1 | $73.4M | Buy |
973,559
+162,039
| +20% | +$12.9M | 0.13% | 134 |
|
|
2017
Q4 | $58.1M | Buy |
811,520
+807,547
| +20,326% | +$61.3M | 0.1% | 154 |
|
|
2017
Q3 | $321K | Sell |
3,973
-714,556
| -99% | -$54.6M | ﹤0.01% | 745 |
|
|
2017
Q2 | $50.9M | Buy |
718,529
+713,083
| +13,094% | +$47.5M | 0.1% | 147 |
|
|
2017
Q1 | $369K | Sell |
5,446
-2,290
| -30% | -$161K | ﹤0.01% | 770 |
|
|
2016
Q4 | $553K | Buy |
7,736
+918
| +13% | +$68.2K | ﹤0.01% | 728 |
|
|
2016
Q3 | $539K | Sell |
6,818
-1,345
| -16% | -$109K | ﹤0.01% | 717 |
|
|
2016
Q2 | $680K | Sell |
8,163
-129,350
| -94% | -$11.5M | ﹤0.01% | 718 |
|
|
2016
Q1 | $12.6M | Sell |
137,513
-72,389
| -34% | -$6.53M | 0.03% | 328 |
|
|
2015
Q4 | $21.2M | Buy |
209,902
+40,408
| +24% | +$4.2M | 0.05% | 245 |
|
|
2015
Q3 | $16.6M | Buy |
169,494
+35,970
| +27% | +$3.99M | 0.04% | 260 |
|
|
2015
Q2 | $15.6M | Sell |
133,524
-19,571
| -13% | -$2.14M | 0.03% | 297 |
|
|
2015
Q1 | $15M | Buy |
153,095
+78,118
| +104% | +$7.93M | 0.03% | 297 |
|
|
2014
Q4 | $7.07M | Sell |
74,977
-79,528
| -51% | -$8.23M | 0.02% | 469 |
|
|
2014
Q3 | $16.4M | Buy |
154,505
+219
| +0.1% | +$21.4K | 0.04% | 280 |
|
|
2014
Q2 | $12.8M | Sell |
154,286
-3,369,687
| -96% | -$262M | 0.03% | 347 |
|
|
2014
Q1 | $250M | Sell |
3,523,973
-170,421
| -5% | -$13.4M | 0.56% | 57 |
|
|
2013
Q4 | $278M | Buy |
3,694,394
+54,704
| +2% | +$3.81M | 0.62% | 48 |
|
|
2013
Q3 | $229M | Sell |
3,639,690
-575,851
| -14% | -$34.4M | 0.54% | 54 |
|
|
2013
Q2 | $216M | Buy |
+4,215,541
| New | +$220M | 0.51% | 56 |
|
Other funds holding GILD
VCM
VPM
Lazard Asset Management's GILD Position: Q1 2026 in Review
Lazard Asset Management reduced its Gilead Sciences (GILD) stake by 0.35% in Q1 2026, selling an estimated $147K and leaving 299,734 shares worth $41.8M. The position accounts for 0.07% of the portfolio, ranked #237.
Lazard Asset Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $278M in Q4 2013. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Lazard Asset Management held 299,734 shares of Gilead Sciences worth $41.8M as of Q1 2026.
- Lazard Asset Management sold 1,053 Gilead Sciences shares in Q1 2026, an estimated $147K.
- Gilead Sciences made up 0.07% of Lazard Asset Management's portfolio in Q1 2026, its #237 holding.
- Lazard Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Lazard Asset Management's Gilead Sciences position peaked at $278M in Q4 2013.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.